These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38340982)

  • 21. Risk of underlying chronic medical conditions for invasive pneumococcal disease in adults.
    Baxter R; Yee A; Aukes L; Snow V; Fireman B; Atkinson B; Klein NP
    Vaccine; 2016 Aug; 34(36):4293-7. PubMed ID: 27396493
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Missed opportunities in antipneumococcal vaccination. Can something more be done for prevention?
    Arencibia Jiménez M; Navarro Gracia JF; Delgado de Los Reyes JA; Pérez Torregrosa G; López Parra D; López García P
    Arch Bronconeumol; 2014 Mar; 50(3):93-8. PubMed ID: 24315186
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serotype distribution and antimicrobial susceptibility of invasive Streptococcus pneumoniae isolates among adult and elderly population before and after introduction of pneumococcal conjugate vaccine in Casablanca, Morocco.
    Nzoyikorera N; Diawara I; Katfy M; Katfy K; Maaloum F; Nyandwi J; Belabbes H; Elmdaghri N; Zerouali K
    BMC Infect Dis; 2023 Jan; 23(1):24. PubMed ID: 36639755
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Invasive pneumococcal disease in infants younger than 90 days before and after introduction of PCV7.
    Olarte L; Ampofo K; Stockmann C; Mason EO; Daly JA; Pavia AT; Byington CL
    Pediatrics; 2013 Jul; 132(1):e17-24. PubMed ID: 23733800
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Streptococcus pneumoniae--a review of carriage, infection, serotype replacement and vaccination.
    Mehr S; Wood N
    Paediatr Respir Rev; 2012 Dec; 13(4):258-64. PubMed ID: 23069126
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term impact of 10-valent pneumococcal conjugate vaccination on invasive pneumococcal disease among children in Finland.
    Rinta-Kokko H; Palmu AA; Auranen K; Nuorti JP; Toropainen M; Siira L; Virtanen MJ; Nohynek H; Jokinen J
    Vaccine; 2018 Apr; 36(15):1934-1940. PubMed ID: 29526371
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Invasive Pneumococcal Disease Following the Introduction of 13-Valent Conjugate Vaccine in Children in New York City From 2007 to 2012.
    Farnham AC; Zimmerman CM; Papadouka V; Konty KJ; Zucker JR; Nattanmai GV; Jose S; Rosen JB
    JAMA Pediatr; 2015 Jul; 169(7):646-52. PubMed ID: 25938798
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Invasive Pneumococcal Disease Among Immunocompromised Persons: Implications for Vaccination Programs.
    Shigayeva A; Rudnick W; Green K; Chen DK; Demczuk W; Gold WL; Johnstone J; Kitai I; Krajden S; Lovinsky R; Muller M; Powis J; Rau N; Walmsley S; Tyrrell G; Bitnun A; McGeer A;
    Clin Infect Dis; 2016 Jan; 62(2):139-47. PubMed ID: 26354970
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decline in Pneumococcal Disease Attenuated in Older Adults and Those With Comorbidities Following Universal Childhood PCV13 Immunization.
    Pelton SI; Bornheimer R; Doroff R; Shea KM; Sato R; Weycker D
    Clin Infect Dis; 2019 May; 68(11):1831-1838. PubMed ID: 30239637
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Population-based incidence of invasive pneumococcal disease in children and adults in Ontario and British Columbia, 2002-2018: A Canadian Immunization Research Network (CIRN) study.
    Nasreen S; Wang J; Kwong JC; Crowcroft NS; Sadarangani M; Wilson SE; McGeer A; Kellner JD; Quach C; Morris SK; Sander B; Kus JV; Naus M; Hoang L; Rudzicz F; Fadel S; Marra F
    Vaccine; 2021 Dec; 39(52):7545-7553. PubMed ID: 34810001
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of pneumococcal conjugate vaccines on the incidence of invasive pneumococcal disease caused by ten non-vaccine serotypes in Denmark.
    Slotved HC; Dalby T; Hoffmann S
    Vaccine; 2016 Feb; 34(6):769-74. PubMed ID: 26772630
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of ten-valent pneumococcal conjugate vaccine on invasive pneumococcal disease and nasopharyngeal carriage in Kenya: a longitudinal surveillance study.
    Hammitt LL; Etyang AO; Morpeth SC; Ojal J; Mutuku A; Mturi N; Moisi JC; Adetifa IM; Karani A; Akech DO; Otiende M; Bwanaali T; Wafula J; Mataza C; Mumbo E; Tabu C; Knoll MD; Bauni E; Marsh K; Williams TN; Kamau T; Sharif SK; Levine OS; Scott JAG
    Lancet; 2019 May; 393(10186):2146-2154. PubMed ID: 31000194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surveillance for invasive pneumococcal disease during 2000-2005 in a population of children who received 7-valent pneumococcal conjugate vaccine.
    Black S; France EK; Isaacman D; Bracken L; Lewis E; Hansen J; Fireman B; Austrian R; Graepel J; Gray S; Klein NP
    Pediatr Infect Dis J; 2007 Sep; 26(9):771-7. PubMed ID: 17721369
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of Pneumococcal Conjugate Vaccines on Antibiotic-Nonsusceptible Invasive Pneumococcal Disease in the United States.
    Bajema KL; Gierke R; Farley MM; Schaffner W; Thomas A; Reingold AL; Harrison LH; Lynfield R; Burzlaff KE; Petit S; Barnes M; Torres S; Vagnone PMS; Beall B; Pilishvili T
    J Infect Dis; 2022 Aug; 226(2):342-351. PubMed ID: 35481950
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Invasive pneumococcal disease and the potential for prevention by vaccination in the United Kingdom.
    Parsons HK; Metcalf SC; Tomlin K; Read RC; Dockrell DH
    J Infect; 2007 May; 54(5):435-8. PubMed ID: 17052760
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changing epidemiology of invasive pneumococcal disease in Canada, 1998-2007: update from the Calgary-area Streptococcus pneumoniae research (CASPER) study.
    Kellner JD; Vanderkooi OG; MacDonald J; Church DL; Tyrrell GJ; Scheifele DW
    Clin Infect Dis; 2009 Jul; 49(2):205-12. PubMed ID: 19508165
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Persistent Sex Disparities in Invasive Pneumococcal Diseases in the Conjugate Vaccine Era.
    de St Maurice A; Schaffner W; Griffin MR; Halasa N; Grijalva CG
    J Infect Dis; 2016 Sep; 214(5):792-7. PubMed ID: 27247342
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HIV Infection and the Epidemiology of Invasive Pneumococcal Disease (IPD) in South African Adults and Older Children Prior to the Introduction of a Pneumococcal Conjugate Vaccine (PCV).
    Meiring S; Cohen C; Quan V; de Gouveia L; Feldman C; Karstaedt A; Klugman KP; Madhi SA; Rabie H; Sriruttan C; von Gottberg A;
    PLoS One; 2016; 11(2):e0149104. PubMed ID: 26863135
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in the Nature and Severity of Invasive Pneumococcal Disease in Children Before and After the Seven-valent and Thirteen-valent Pneumococcal Conjugate Vaccine Programs in Calgary, Canada.
    Ricketson LJ; Conradi NG; Vanderkooi OG; Kellner JD
    Pediatr Infect Dis J; 2018 Jan; 37(1):22-27. PubMed ID: 28737622
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk factors for invasive pneumococcal disease in a community with a high proportion of non vaccine serotypes.
    Ciruela P; Soldevila N; Hernández S; Selva L; de Sevilla MF; García-García JJ; Moraga F; Planes AM; Muñoz-Almagro C; Domínguez A
    Vaccine; 2013 Jan; 31(6):960-6. PubMed ID: 23261046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.